Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)
National Institutes of Health opportunity PAR-25-051
Organization Types
UniversitiesNGOsSMEsGovernment Agencies
Eligible Countries / Regions
National Institutes of HealthPAR-25-051Grants.gov